Interchangeability of CSF and PET to identify Alzheimer's disease pathology

Abstract INTRODUCTION Establishing interchangeability between cerebrospinal fluid (CSF) and positron emission tomography (PET) for patient identification may improve access to Alzheimer's disease (AD) therapies. METHODS Alzheimer's Disease Neuroimaging Initiative participants with mild cognitive imp...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Samantha C. Burnham, Anupa K. Arora, Leonardo Iaccarino, Ian Kennedy, Vikas Kotari, Sameera R. Wijayawardana, Leslie M. Shaw, Natalya Benina, Ming Lu, Michael J. Pontecorvo, Frances‐Catherine Quevenco, Jian Wang, Alzheimer's Disease Neuroimaging Initiative
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Wiley 2026-04-01
סדרה:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
נושאים:	Alzheimer's disease diagnosis AD pathology Alzheimer's disease amyloid beta biomarker concordance analysis
גישה מקוונת:	https://doi.org/10.1002/dad2.70288
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!